Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.
|Number of pages||4|
|Journal||The International Journal of Chronic Obstructive Pulmonary Disease|
|Publication status||Published - 2021|